Cargando…

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma

BACKGROUND: There is currently no effective treatment for advanced hepatocellular carcinoma (HCC), and chemotherapy has little effect on long-term survival of HCC patients, largely due to the cancer stem cell (CSC) chemoresistance of HCC. METHODS: We constructed a small-molecule nanometer-sized prod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501963/ https://www.ncbi.nlm.nih.gov/pubmed/32982236 http://dx.doi.org/10.2147/IJN.S236928

Ejemplares similares

Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs
por: Lee, Bong-Seop, et al.
Publicado: (2011)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
por: Tao, Yaoye, et al.
Publicado: (2020)

Hydrophilic Fluorescent Nanoprodrug of Paclitaxel for Glioblastoma Chemotherapy
por: Daniel, Jonathan, et al.
Publicado: (2019)

Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment
por: Li, Guoyin, et al.
Publicado: (2023)

Salinomycin-loaded Nanofibers for Glioblastoma Therapy
por: Norouzi, Mohammad, et al.
Publicado: (2018)

Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
por: Xiang, Xiujuan, et al.
Publicado: (2022)

Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications
por: Wang, Hui, et al.
Publicado: (2021)

Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Synthesis, Anticancer and Antibacterial Activity of Salinomycin N-Benzyl Amides
por: Antoszczak, Michał, et al.
Publicado: (2014)

Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review
por: Jiang, Jiang, et al.
Publicado: (2018)

An erythrocyte-delivered photoactivatable oxaliplatin nanoprodrug for enhanced antitumor efficacy and immune response
por: Wang, Na, et al.
Publicado: (2021)

Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy
por: Norouzi, Mohammad, et al.
Publicado: (2020)

A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity
por: Li, Yawei, et al.
Publicado: (2021)

Site-Specific Modification of the Anticancer and Antituberculosis Polyether Salinomycin by Biosynthetic Engineering
por: Luhavaya, Hanna, et al.
Publicado: (2014)

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
por: Wang, Hangxiang, et al.
Publicado: (2018)

Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo
por: Wang, Fan, et al.
Publicado: (2012)

Silica nanoparticle-based dual-responsive nanoprodrug system for liver cancer therapy
por: Xia, Qing, et al.
Publicado: (2017)

Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy
por: Li, Zekun, et al.
Publicado: (2022)

Comparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method
por: Wang, Qin, et al.
Publicado: (2014)

Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells
por: Fu, Changhao, et al.
Publicado: (2019)

Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast
por: Yang, Zhentao, et al.
Publicado: (2021)

Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice
por: Clond, Morgan A., et al.
Publicado: (2013)

Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology
por: Ando, Takashi, et al.
Publicado: (2021)

Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
por: Qi, Dan, et al.
Publicado: (2021)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma
por: Wang, Fan, et al.
Publicado: (2014)

Structure-Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy**
por: Wang, Hangxiang, et al.
Publicado: (2014)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy
por: Liu, Zheng, et al.
Publicado: (2023)

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma
por: Zhang, Xuanyu, et al.
Publicado: (2019)

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux
por: Liu, Yajing, et al.
Publicado: (2020)

Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo
por: Zhang, Yunsheng, et al.
Publicado: (2017)

Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS
por: Wang, Jinping, et al.
Publicado: (2022)

Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells
por: Klose, Johannes, et al.
Publicado: (2014)

Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression
por: XU, LING, et al.
Publicado: (2015)

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy
por: Zhang, Xi-Feng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4o8vqu7jb44jo321iu207886b6